top of page
Learn more - About

Data Governance in a Zettabyte World: Implications for R&D













In a world characterised by unprecedented generation, storage and utilisation of data on a massive scale, the biopharmaceutical industry has been compelled to adapt from the use of conventional paper-based processes, through electronic capture of discrete data, to the ability to receive, collect and analyse continuous data from multiple, remote, patient-managed devices.


This paper presents a high-level data governance framework, a SWOT analysis for data governance in biopharmaceutical R&D, and explores challenges in decentralised R&D clinical trials. Finally, an operating model framework is presented that addresses governance of data in a more holistic way that facilitates the development of a more robust and integrated design.


Stephen Gunnigle

Aidan Walker

Dimitrios Alexopoulos

- Published October 2023 - 

Data governance paper_edited.jpg
bottom of page